We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
-14.03%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$22.9B
AUM Growth
-$4.32B
Cap. Flow
-$424M
Cap. Flow %
-1.85%
Top 10 Hldgs %
13.89%
Holding
1,428
New
104
Increased
438
Reduced
568
Closed
134

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$499M
2
BMY icon
Bristol-Myers Squibb
BMY
+$59.2M
3
HUM icon
Humana
HUM
+$54.1M
4
EMR icon
Emerson Electric
EMR
+$47.7M
5
TGT icon
Target
TGT
+$45.5M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$68.5M
2
SYK icon
Stryker
SYK
+$50.3M
3
JNJ icon
Johnson & Johnson
JNJ
+$46.2M
4
NVDA icon
NVIDIA
NVDA
+$44.1M
5
SWK icon
Stanley Black & Decker
SWK
+$40.5M

Sector Composition

Rank Sector Weight
1 Technology 20.58%
2 Healthcare 15.8%
3 Financials 11.35%
4 Consumer Discretionary 9.79%
5 Industrials 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EVTC icon
1301
Evertec
EVTC
$1.97B
– –
-49,800
Closed -$1.2M
FAF icon
1302
First American
FAF
$7.98B
– –
-4,200
Closed -$217K
FBNC icon
1303
First Bancorp
FBNC
$2.61B
– –
-12,900
Closed -$523K
GHC icon
1304
Graham Holdings Company
GHC
$5.31B
– –
-18,672
Closed -$10.8M
GOGL
1305
DELISTED
Golden Ocean Group
GOGL
– –
-27,000
Closed -$266K
HRTX icon
1306
Heron Therapeutics
HRTX
$93.4M
– –
-27,900
Closed -$883K
HUBG icon
1307
HUB Group
HUBG
$2.92B
– –
-15,200
Closed -$347K
ICL icon
1308
ICL Group
ICL
$6.58B
– –
-30,000
Closed -$181K
IDV icon
1309
iShares International Select Dividend ETF
IDV
$8.31B
– –
-6,399
Closed -$209K
IFF icon
1310
International Flavors & Fragrances
IFF
$20.3B
– –
-30,023
Closed -$4.18M
IMMR icon
1311
Immersion
IMMR
$243M
– –
-34,200
Closed -$361K
INGN icon
1312
Inogen
INGN
$174M
– –
-6,500
Closed -$1.59M
JBL icon
1313
Jabil
JBL
$30.1B
– –
-290,800
Closed -$7.88M
KGC icon
1314
Kinross Gold
KGC
$27.7B
– –
-52,900
Closed -$143K
KOP icon
1315
Koppers
KOP
$946M
– –
-18,700
Closed -$583K
KRO icon
1316
KRONOS Worldwide
KRO
$712M
– –
-334,300
Closed -$5.43M
LADR
1317
Ladder Capital
LADR
$1.24B
– –
-12,200
Closed -$207K
LCII icon
1318
LCI Industries
LCII
$2.59B
– –
-15,114
Closed -$1.25M
LDOS icon
1319
Leidos
LDOS
$14.4B
– –
-208,034
Closed -$14.4M
LGIH icon
1320
LGI Homes
LGIH
$1.35B
– –
-6,300
Closed -$299K
LIVN icon
1321
LivaNova
LIVN
$4.47B
– –
-4,400
Closed -$545K
LOPE icon
1322
Grand Canyon Education
LOPE
$4.22B
– –
-3,700
Closed -$417K
LRN icon
1323
Stride
LRN
$4.16B
– –
-224,100
Closed -$3.97M
MHK icon
1324
Mohawk Industries
MHK
$6.91B
– –
-8,762
Closed -$1.54M
MKL icon
1325
Markel Group
MKL
$25.2B
– –
-186
Closed -$221K
51 52
53
54 55

Similar funds

PHAM
Palisades Hudson Asset Management Fort Lauderdale, Florida $257M AUM 21.62% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
EBWM
Eagle Bluffs Wealth Management Columbia, Missouri $257M AUM 30.19% 1-Year Est. Return
GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
CIA
Corigliano Investment Advisers Raleigh, North Carolina $256M AUM 54.89% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return

Axa's Q4 2018 Portfolio in Review

As of Q4 2018, Axa held 1,428 positions worth $22.9B, down 16% from $27.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q4 2018 filing shows 104 new, 438 increased, 568 reduced and 134 closed positions. Its largest new stake was Linde: 3,157,617 shares worth $493M. The largest sale was Hologic, an estimated $68.5M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2018 buy was Linde: 3,157,617 shares worth $493M.
  • Axa added most to Bristol-Myers Squibb in Q4 2018, an estimated $59.2M increase.
  • Axa's biggest Q4 2018 reduction was Hologic, cutting an estimated $68.5M.
  • Axa fully exited Praxair Inc in Q4 2018, selling an estimated $25.6M.
  • Axa's ten largest holdings make up 14% of its $22.9B portfolio in Q4 2018.
  • Axa opened 104 new positions and closed 134 in Q4 2018.
  • Axa's portfolio value fell 16% quarter-over-quarter to $22.9B.

Based on Axa's 13F filing for Q4 2018, filed 13 Feb 2019.